Andi Orlowski

Andi Orlowskis headshot

Andi Orlowski

Andi Orlowski is a health economist and the Director of the Health Economics Unit, an NHS organisation supporting health and care locally, regionally and nationally, providing expertise in economics, population health, analytics and evaluations.

With a passion for population health analytics, Andi is excited about addressing health inequalities and the concept of impactibility modelling. He is researching this for his PhD at Imperial College London.

Andi is:

  • Senior Advisor for NHS England on Population Health Management in the Data and Analytics Directorate, working with and advising Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs).
  • Non-Executive Director and Lead for Collaboration and Clinical Engagement at AphA Analysts, a community interest company, aiming to raise the profile of healthcare analysts and provide a professional support network.
  • A Council Member at the Healthcare Financial Management Association (HFMA) which provides independent support and guidance to its members and the wider healthcare community.

Meet the rest of our passionate team.

Selected publications

  • Orlowski A, Gale CP, Ashton R, Petrungaro B, Slater R, Nadarajah R, et al. Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation. Heart. 2021;107(1):47-53.
  • Buck J, Fromings Hill J, Martin A, Springate C, Ghosh B, Ashton R, and Orlowski A. Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review. Age Ageing. 2021.
  • Wong KY, Davies B, Adeleke Y, Woodcock T, Matthew D, Sekelj S, et al. Hospital admissions for stroke and bleeding in Hounslow following a quality improvement initiative. Open Heart. 2021;8(1).
  • De Oliveira H, Prodel M, Lamarsalle L, Inada-Kim M, Ajayi K, Wilkins J and Orlowski A. “Bow-tie” optimal pathway discovery analysis of sepsis hospital admissions using the Hospital Episode Statistics database in England. JAMIA Open. 2020;3(3):439-48.
  • Orlowski A, Wilkins J, Ashton R, Slater R, Smith W, Belsey J. Budget impacts associated with improving diagnosis and treatment of atrial fibrillation in high-risk stroke patients. J Comp Eff Res. 2020;9(4):253-62.
  • Cowan JC, Wu J, Hall M, Orlowski A, West RM, Gale CP. A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J. 2018;39(32):2975-83.

Our specialist services

This is a small selection of all the solutions we can provide.

Evaluation service

Understanding whether new care pathways and interventions are effective, efficient, and deliver value for money is vital.

Economic evaluations

Inform your decision-making by quantifying the expected health benefits and costs related to alternative options.

Demand and capacity modelling

Understand pathways and how different elements come together, assess and explain current service levels and variations in demand.

Population health analytics

Identify patterns of health outcomes in different groups and understand the challenges and risks they face.